Britain approves worlds first oral pill ‘molnupiravir’ to treat Covid-19
- The health regulators of Britain have approved the world’s first pill to treat cases of symptomatic COVID-19.
- The pill named Lagevrio (molnupiravir) has been approved by Medicines and Healthcare Products Regulatory Agency (MHRA).
- The molnupiravir pill is safe and effective at reducing the risk of hospitalisation and death in people with mild to moderate COVID-19, who are at increased risk of developing severe disease.
Points to Remember:
- Which country has launched world’s first pill to treat cases of symptomatic COVID-19?
- Name of the world’s first pill launched by Britain to treat cases of symptomatic COVID-19